The partnership allows enterprises to procure Aily’s platform using existing Google Cloud commitments, effectively eliminating redundant security reviews and separate vendor onboarding processes. Once provisioned, the company’s AI agents integrate into the Gemini Enterprise Agent Gallery, providing a unified interface for operational oversight. Bianca Diana Anghelina, CEO and founder of Aily Labs, noted that the distribution milestone simplifies how customers transform raw information into immediate action.
Aily Labs Integrates Decision Intelligence into Google Cloud
Pharmaceutical and biotech firms can now deploy Aily Labs’ AI agents directly through Google Cloud Marketplace, bypassing traditional procurement hurdles. By embedding its decision-making platform into Gemini Enterprise, Aily aims to bridge the gap between fragmented corporate data silos and real-time business execution for global life sciences leaders.
Shweta Maniar, global director of Life Sciences Strategy & Solutions at Google Cloud, emphasized that the collaboration targets the specific pain point of data fragmentation across research, manufacturing, and supply chains. Aily’s "Super Agent" architecture coordinates thousands of specialized models to offer recommendations across finance, R&D, and commercial operations. This technical stack leverages Google’s BigQuery and Gemini models to enable autonomous, high-stakes decision-making. Founded in 2020, Aily Labs previously secured $80 million in funding last November, bringing its total capital raised to over $101 million to support its expansion into enterprise-scale AI deployment.
Comments (0)
No comments yet. Be the first!